Teacher Retirement System of Texas acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 18,817 shares of the company's stock, valued at approximately $447,000.
Other institutional investors have also bought and sold shares of the company. GAMMA Investing LLC lifted its stake in Surgery Partners by 7,902.7% in the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after purchasing an additional 8,772 shares during the last quarter. Northern Trust Corp raised its holdings in Surgery Partners by 2.1% during the 4th quarter. Northern Trust Corp now owns 761,790 shares of the company's stock valued at $16,127,000 after acquiring an additional 15,657 shares during the period. Norges Bank bought a new stake in Surgery Partners during the 4th quarter valued at $15,796,000. Deutsche Bank AG raised its holdings in Surgery Partners by 20.4% during the 4th quarter. Deutsche Bank AG now owns 96,512 shares of the company's stock valued at $2,043,000 after acquiring an additional 16,340 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in Surgery Partners by 8.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 834,417 shares of the company's stock valued at $17,665,000 after acquiring an additional 61,671 shares during the period.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on SGRY shares. Barclays lowered their target price on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Benchmark reaffirmed a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a report on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $33.56.
Read Our Latest Research Report on Surgery Partners
Surgery Partners Price Performance
SGRY traded up $0.04 during midday trading on Monday, hitting $22.36. The stock had a trading volume of 1,317,212 shares, compared to its average volume of 1,201,135. The business has a fifty day moving average of $22.43 and a 200 day moving average of $22.81. Surgery Partners, Inc. has a 1 year low of $18.87 and a 1 year high of $33.97. The company has a market cap of $2.87 billion, a P/E ratio of -14.61 and a beta of 1.90. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). Surgery Partners had a negative net margin of 6.10% and a positive return on equity of 2.41%. The company had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. During the same period last year, the business posted $0.10 earnings per share. The firm's quarterly revenue was up 8.2% compared to the same quarter last year. As a group, equities analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.
Surgery Partners Company Profile
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles

Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.